[BREAKING NEWS] SUCCESS! Gilead's Remdesivir Succeeded in Critical Trial Against COVID-19, Raising Hopes for a Coronavirus Cure Biotech company Gilead shared some good news as remdesivir, one of the leading candidates for COVID-19 cure, succeeded in a crucial trial. by Nhx Tingson
Health Pharma Giant Gilead Retracts Orphan Drug Status After Allegedly Trying to Monopolize Coronavirus Cure by Urian B.
Healthy Living/Wellness Gilead Sciences Buys Nimbus Therapeutics' Liver Drug Program For $1.2 Billion by Rina Marie Doctor
Healthy Living/Wellness Jury Favors Merck Over Gilead In Hepatitis C Drug Patent Dispute by Rhodi Lee
Healthy Living/Wellness Gilead Pricing Strategy For Hepatitis C Drug Sovaldi Focused on Maximizing Profits Not Patients: Report by Katrina Pascual
Healthy Living/Wellness China Rejects Patent Application Of Gilead For $1,000 A Day Hepatitis C Drug Sovaldi by Rhodi Lee
Healthy Living/Wellness Gilead Fights For Hepa C Drug Patents: Activists Concerned About Drug Accessibility by Dianne Depra
Healthy Living/Wellness FDA approves Gilead's Harvoni drug: Can we afford the $1125 once-a-day Hepatitis C pill? by Aaron Mamiit
Healthy Living/Wellness Sovaldi hepatitis C drug at $84,000 per treatment course sparks healthcare concerns by Rhodi Lee
Healthy Living/Wellness Zydelig (idelalisib) gets FDA approval for 3 types of cancer: Another Gilead blockbuster drug? by Rhodi Lee
Healthy Living/Wellness Senate Committee asks Gilead why Hepatitis C drug Sovaldi costs $1000 a pill by James Maynard
Healthy Living/Wellness Senate asks Gilead Sciences to explain itself, high cost of Hep C drug by Tina Shah
Healthy Living/Wellness New hepatitis C treatment very effective: Over 90 percent success rate in patients with cirrhosis by Rhodi Lee
Healthy Living/Wellness Sovaldi for hepatitis C from Gilead may kill the virus but can anyone buy it at $84,000? by Rhodi Lee
Healthy Living/Wellness Gilead Sciences' blockbuster $84k Hepatitis C drug has just made its CEO a billionaire by Rhodilee Jean Dolor